Global Med Technologies(R), Inc. Retains The Investor Relations Group
February 01 2005 - 10:00AM
PR Newswire (US)
Global Med Technologies(R), Inc. Retains The Investor Relations
Group DENVER, Feb. 1 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. ("Global Med") (OTC:GLOB) (BULLETIN BOARD:
GLOB) has engaged The Investor Relations Group, Inc. ("IRG"), based
in New York City, to serve as its financial relations company.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
IRG will strive to increase investor awareness of Global Med within
the U.S. market by individually and personally introducing Global
Med and its management to pre-qualified investment professionals.
"We are very pleased with Global Med's progress in the domestic and
international market place. Our revenues in the third quarter were
up 40% from the comparable quarter in 2003. Our business continues
to trend higher, as we recently announced that our products are
installed at over 300 locations, and are well positioned to drive
double digit growth and positive cash flow from operations on an
annual basis," said Michael I. Ruxin, M.D., Chairman and CEO of
Global Med Technologies. Dr. Ruxin added, "In line with this
progress, management is focused on maximizing shareholder value. A
key component of this effort will be to increase investor awareness
of Global Med. We look forward to working with the IRG team to
achieve this goal." In the future, U.S. investor inquiries relating
to Global Med can be directed to The Investor Relations Group, New
York, NY, Telephone: (212) 825-3210, E-Mail: . About Global Med
Technologies(R), Inc. Global Med Technologies, Inc., based in
Denver, Colorado, designs, develops, markets and supports
information management software products for blood banks,
hospitals, centralized transfusion centers and other healthcare
related facilities. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Sahara Africa. Together, the
SafeTrace Tx(R)* advanced transfusion management system and the
SafeTrace(R) donor management system provide Vein-to-Vein(R)
tracking from donor collection to patient transfusion. Please visit
the Global Med website at: http://www.globalmedtech.com/. *Patent
Pending About The Investor Relations Group The Investor Relations
Group, Inc., (IRG) founded in 1996, represents select publicly
traded companies, with a unique specialization for assisting those
in the small-cap sector. IRG arranges one-on-one meetings for its
portfolio companies with pre-qualified money managers handling
investment portfolios that range from $10 million to $10 billion+,
selected from its proprietary contact base of over 27,000 qualified
fund managers who have an investing history in small cap stocks.
IRG is a full-service corporate communications company offering
services for its portfolio companies that include writing all press
releases and shareholder communications, and serving as primary
contact for the investing community. IRG also houses a full-service
public relations arm that specializes in building awareness of its
companies within the financial and trade media, as well as the
public at large. For further information, please visit the
company's website at http://www.investorrelationsgroup.com/. This
news release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2009; or Investor Relations, John Nesbett or Sari
Clement, both of The Investor Relations Group, +1-212-825-3210 Web
site: http://www.globalmedtech.com/
Copyright